Cytokinetics Inc (STU:KK3A)
€ 46.8 -0.8 (-1.68%) Market Cap: 5.58 Bil Enterprise Value: 5.34 Bil PE Ratio: 0 PB Ratio: 56.37 GF Score: 56/100

Cytokinetics Inc at JMP Securities Life Sciences Conference Transcript

May 15, 2023 / 01:00 PM GMT
Release Date Price: €34.2 (-0.58%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CYTK.OQ - Cytokinetics Inc
Cytokinetics Inc at JMP Securities Life Sciences Conference
May 15, 2023 / 01:00PM GMT

=====================
Conference Call Participants
=====================
* Jason Butler
JMP group LLC - Research analysit
* Robert I. Blum
Cytokinetics Inc - President and Chief Executive Officer

=====================
Presentation
--------------------------------------------------------------------------------
Jason Butler, JMP group LLC - Research analysit [1]
--------------------------------------------------------------------------------
Good morning, and welcome everybody, to the JMP Securities Life Science Conference. Really excited to have everybody with us this morning. I'm Jay Jason Butler with research here at JMP. I'm really excited to kick off with Cytokinetics. I'm joined here by CEO, Robert Blum, another exciting year, really important year for the Company with Phase-3 results for their most advanced candidate Africa, Hampton Inn, obstructive hypertrophic
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot